Cargando…

Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells

BACKGROUND: The morbidity and mortality of human immunodeficiency virus (HIV)-infection is often associated with liver disease, which progresses slowly into severe liver dysfunction. There are multiple insults which exacerbate HIV-related liver injury, including HIV-associated dysregulation of lipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	New-Aaron, Moses, Ganesan, Murali, Dagur, Raghubendra Singh, Kharbanda, Kusum K, Poluektova, Larisa Y, Osna, Natalia A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701963/ https://www.ncbi.nlm.nih.gov/pubmed/33312422 http://dx.doi.org/10.4254/wjh.v12.i11.965

Ejemplares similares

Pancreatogenic Diabetes: Triggering Effects of Alcohol and HIV
por: New-Aaron, Moses, et al.
Publicado: (2021)

Alcohol Metabolism Potentiates HIV-Induced Hepatotoxicity: Contribution to End-Stage Liver Disease
por: Ganesan, Murali, et al.
Publicado: (2019)

Alcohol-and-HIV-Induced Lysosomal Dysfunction Regulates Extracellular Vesicles Secretion in Vitro and in Liver-Humanized Mice
por: Dagur, Raghubendra Singh, et al.
Publicado: (2021)

Alcohol-Induced Lysosomal Damage and Suppression of Lysosome Biogenesis Contribute to Hepatotoxicity in HIV-Exposed Liver Cells
por: New-Aaron, Moses, et al.
Publicado: (2021)

Alcohol and HIV-Derived Hepatocyte Apoptotic Bodies Induce Hepatic Stellate Cell Activation
por: New-Aaron, Moses, et al.
Publicado: (2022)

Liver as a target of human immunodeficiency virus infection
por: Ganesan, Murali, et al.
Publicado: (2018)

Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
por: Ganesan, Murali, et al.
Publicado: (2019)

Role of alcohol in pathogenesis of hepatitis B virus infection
por: Ganesan, Murali, et al.
Publicado: (2020)

Increased liver stiffness promotes hepatitis B progression by impairing innate immunity in CCl4-induced fibrotic HBV(+) transgenic mice
por: Bybee, Grace, et al.
Publicado: (2023)

Cell-to-Cell Communications in Alcohol-Associated Liver Disease
por: Osna, Natalia A., et al.
Publicado: (2022)

Hepatitis C Virus-Infected Apoptotic Hepatocytes Program Macrophages and Hepatic Stellate Cells for Liver Inflammation and Fibrosis Development: Role of Ethanol as a Second Hit
por: Ganesan, Murali, et al.
Publicado: (2018)

Demethylase JMJD6 as a New Regulator of Interferon Signaling: Effects of HCV and Ethanol Metabolism
por: Ganesan, Murali, et al.
Publicado: (2017)

Hepatocyte-Specific Triggering of Hepatic Stellate Cell Profibrotic Activation by Apoptotic Bodies: The Role of Hepatoma-Derived Growth Factor, HIV, and Ethanol
por: New-Aaron, Moses, et al.
Publicado: (2023)

A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin
por: Kharbanda, Kusum K., et al.
Publicado: (2023)

Hepatitis C, Innate Immunity and Alcohol: Friends or Foes?
por: Osna, Natalia A., et al.
Publicado: (2015)

Human hepatocyte depletion in the presence of HIV-1 infection in dual reconstituted humanized mice
por: Dagur, Raghubendra Singh, et al.
Publicado: (2018)

Prolonged feeding with guanidinoacetate, a methyl group consumer, exacerbates ethanol-induced liver injury
por: Osna, Natalia A, et al.
Publicado: (2016)

Bifunctional Enzyme JMJD6 Contributes to Multiple Disease Pathogenesis: New Twist on the Old Story
por: Vangimalla, Shiva Shankar, et al.
Publicado: (2017)

Multi-Organ Alcohol-Related Damage: Mechanisms and Treatment
por: Osna, Natalia A., et al.
Publicado: (2016)

Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
por: Singh, Sukhpreet, et al.
Publicado: (2017)

Advances in Alcoholic Liver Disease
por: Osna, Natalia, et al.
Publicado: (2012)

Alcoholic Liver Disease: Pathogenesis and Current Management
por: Osna, Natalia A., et al.
Publicado: (2017)

27558 Obeticholic acid (OCALIVA ®) protects against 2,8-dihydroxyadenine nephropathy in mice
por: Jones, Bryce, et al.
Publicado: (2021)

Editorial: Alcohol-associated liver disease—From pathogenesis to treatment
por: Kharbanda, Kusum K., et al.
Publicado: (2022)

Editorial: Cell-to-cell communications in alcohol-associated, metabolic-related and viral liver diseases
por: Osna, Natalia A., et al.
Publicado: (2023)

Beneficial Effects of Betaine: A Comprehensive Review
por: Arumugam, Madan Kumar, et al.
Publicado: (2021)

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

Role of Elevated Intracellular S-Adenosylhomocysteine in the Pathogenesis of Alcohol-Related Liver Disease
por: Arumugam, Madan Kumar, et al.
Publicado: (2020)

Chronic Hepatitis B Infection: New Approaches towards Cure
por: Ogunnaike, Mojisola, et al.
Publicado: (2023)

Lipidomic Analysis of Liver Lipid Droplets after Chronic Alcohol Consumption with and without Betaine Supplementation
por: Arumugam, Madan Kumar, et al.
Publicado: (2023)

Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
por: Paka, Latha, et al.
Publicado: (2017)

Elevated S-adenosylhomocysteine induces adipocyte dysfunction to promote alcohol-associated liver steatosis
por: Arumugam, Madan Kumar, et al.
Publicado: (2021)

Acute ethanol-induced liver injury is prevented by betaine administration
por: Arumugam, Madan Kumar, et al.
Publicado: (2022)

Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Pro-fibrotic SNPs
por: Maxmen, Amy
Publicado: (2009)

Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease
por: Lee, Seung Min, et al.
Publicado: (2023)

The Notch pathway controls fibrotic and regenerative repair in the adult heart
por: Nemir, Mohamed, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3n0blul9u7v03e83nnn3jnlha3